Signal Genetics Inc Share Price Nasdaq
Stocks
US8266401046
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 2.05B 1.8B 1.66B 1.53B 2.89B 198B 2.93B 19.83B 7.77B 96.62B 7.7B 7.53B 333B | P/E 2026 * |
-4.82x | P/E 2027 * | -7.45x |
|---|---|---|---|---|---|
| Enterprise Value | 1.31B 1.15B 1.06B 976M 1.84B 126B 1.87B 12.67B 4.97B 61.75B 4.92B 4.81B 213B | EV / Sales 2026 * |
47.4x | EV / Sales 2027 * | 6.52x |
| Free-Float |
98.8% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Signal Genetics Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Mahoney
CEO | Chief Executive Officer | 55 | 29/10/2023 |
Seth Harmon
DFI | Director of Finance/CFO | 46 | 11/09/2023 |
Kirk Bertelsen
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 74 | 02/01/2018 |
Tomas Kiselak
CHM | Chairman | 39 | 31/05/2021 |
Jennifer Moses
BRD | Director/Board Member | 51 | 13/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.49% | -3.58% | -0.84% | +2.13% | 49.18B | |
| -3.10% | -3.47% | +370.99% | +567.62% | 39.58B | |
| -0.46% | +3.98% | +5.44% | +60.79% | 34.69B | |
| -1.14% | -1.90% | +26.94% | -9.56% | 34.42B | |
| -1.82% | -1.48% | +0.52% | +32.02% | 27.11B | |
| -3.54% | -6.91% | - | - | 16.21B | |
| -1.82% | -1.91% | +69.28% | +112.51% | 15.36B | |
| +1.17% | +3.10% | +15.87% | +16.79% | 14.05B | |
| -2.25% | -0.92% | +15.77% | -32.78% | 13.02B | |
| Average | -1.49% | -0.17% | +63.00% | +93.69% | 27.07B | |
| Weighted average by Cap. | -1.43% | -0.38% | +75.91% | +117.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 27.65M 24.23M 22.41M 20.6M 38.93M 2.67B 39.54M 267M 105M 1.3B 104M 102M 4.49B | 232M 203M 188M 172M 326M 22.33B 331M 2.24B 878M 10.92B 869M 850M 37.62B |
| Net income | -446M -391M -361M -332M -627M -42.97B -637M -4.31B -1.69B -21.01B -1.67B -1.64B -72.41B | -303M -266M -246M -226M -427M -29.23B -433M -2.93B -1.15B -14.29B -1.14B -1.11B -49.25B |
| Net Debt | -740M -648M -599M -551M -1.04B -71.33B -1.06B -7.16B -2.81B -34.87B -2.78B -2.72B -120B | -540M -473M -438M -402M -760M -52.09B -772M -5.22B -2.05B -25.46B -2.03B -1.98B -87.76B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
